The closing price of Staar Surgical Co. (NASDAQ: STAA) was $39.07 for the day, down -1.21% from the previous closing price of $39.55. In other words, the price has decreased by -$0.48 from its previous closing price. On the day, 765866 shares were traded.
Ratios:
Our analysis of STAA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.08 and its Current Ratio is at 5.62. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on March 11, 2024, Upgraded its rating to Buy and sets its target price to $50 from $30 previously.
On December 04, 2023, Morgan Stanley started tracking the stock assigning a Equal-Weight rating and target price of $35.Morgan Stanley initiated its Equal-Weight rating on December 04, 2023, with a $35 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 14 ’24 when WEISNER AIMEE S bought 1,750 shares for $38.11 per share. The transaction valued at 66,692 led to the insider holds 10,864 shares of the business.
BROADWOOD PARTNERS, L.P. bought 4,042 shares of STAA for $109,570 on Jan 08 ’24. The 10% Owner now owns 10,768,430 shares after completing the transaction at $27.11 per share. On Jan 05 ’24, another insider, BROADWOOD PARTNERS, L.P., who serves as the 10% Owner of the company, bought 156,734 shares for $28.48 each. As a result, the insider paid 4,463,231 and bolstered with 10,764,388 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STAA now has a Market Capitalization of 1.93B and an Enterprise Value of 1.75B. As of this moment, Staar’s Price-to-Earnings (P/E) ratio for their current fiscal year is 90.38, and their Forward P/E ratio for the next fiscal year is 44.05. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.01. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.92 while its Price-to-Book (P/B) ratio in mrq is 4.94. Its current Enterprise Value per Revenue stands at 5.42 whereas that against EBITDA is 52.61.
Stock Price History:
Over the past 52 weeks, STAA has reached a high of $73.13, while it has fallen to a 52-week low of $26.66. The 50-Day Moving Average of the stock is 33.45, while the 200-Day Moving Average is calculated to be 39.15.
Shares Statistics:
STAA traded an average of 725.27K shares per day over the past three months and 623.26k shares per day over the past ten days. A total of 48.84M shares are outstanding, with a floating share count of 48.34M. Insiders hold about 1.07% of the company’s shares, while institutions hold 105.58% stake in the company. Shares short for STAA as of Mar 15, 2024 were 5.43M with a Short Ratio of 7.49, compared to 6.45M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 11.12% and a Short% of Float of 23.00%.
Earnings Estimates
The firm’s stock currently is rated by 9 analysts. On average, analysts expect EPS of $0.03 for the current quarter, with a high estimate of $0.11 and a low estimate of -$0.05, while EPS last year was $0.18. The consensus estimate for the next quarter is $0.24, with high estimates of $0.34 and low estimates of $0.17.
Analysts are recommending an EPS of between $0.74 and $0.3 for the fiscal current year, implying an average EPS of $0.57. EPS for the following year is $0.95, with 9 analysts recommending between $1.18 and $0.66.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 11 analysts. It ranges from a high estimate of $72.6M to a low estimate of $72M. As of the current estimate, Staar Surgical Co.’s year-ago sales were $66.96M, an estimated increase of 7.70% from the year-ago figure. For the next quarter, 11 analysts are estimating revenue of $95.02M, an increase of 2.90% less than the figure of $7.70% in the same quarter last year. There is a high estimate of $97.8M for the next quarter, whereas the lowest estimate is $93M.
A total of 13 analysts have provided revenue estimates for STAA’s current fiscal year. The highest revenue estimate was $339M, while the lowest revenue estimate was $335.71M, resulting in an average revenue estimate of $337.21M. In the same quarter a year ago, actual revenue was $322.42M, up 4.60% from the average estimate. Based on 13 analysts’ estimates, the company’s revenue will be $392.4M in the next fiscal year. The high estimate is $403.3M and the low estimate is $382M. The average revenue growth estimate for next year is up 16.40% from the average revenue estimate for this year.
